Skip to Content
Merck

266353

Zinc

99.9% trace metals basis, 2-14 mesh, pieces

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
Zn
CAS Number:
Molecular Weight:
65.39
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
11101719
EC Number:
231-175-3
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

Zinc, pieces, 2-14 mesh, 99.9% trace metals basis

vapor pressure

1 mmHg ( 487 °C)

Quality Level

assay

99.9% trace metals basis

form

pieces

reaction suitability

core: zinc, reagent type: catalyst

resistivity

5.8 μΩ-cm, 20°C

particle size

2-14 mesh

bp

907 °C (lit.)

mp

420 °C (lit.)

density

7.133 g/mL at 25 °C (lit.)

SMILES string

[Zn]

InChI

1S/Zn

InChI key

HCHKCACWOHOZIP-UHFFFAOYSA-N

Application

Reducing agent; reagent used for preparation of organozinc reagents


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Knochel, P.
Chemical Reviews, 93, 217-217 (1993)
Sara Eyal et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 50(5), 798-806 (2009-05-01)
Studies in rodents indicate that the disruption of P-glycoprotein (P-gp) function increases drug distribution into the developing fetus and organs such as the brain. To simultaneously and serially evaluate the effect of P-gp activity and inhibition on the tissue distribution
I A Popov et al.
Molekuliarnaia biologiia, 47(3), 498-504 (2013-07-31)
Alzheimer's disease, is a lethal neurodegenerative pathology, characterized by the formation of soluble neurotoxic oligomers of the human amyloid-beta peptide Abeta which get accumulated forming polymeric extracellular aggregates (so-called amyloid plaques). The isomerized at aspartate 7 isoform of the human